2.43 (-%)
As of Nov 21, 2024
Source:
Black Diamond Therapeutics, Inc is a clinical-stage oncology company focused on the development of MasterKey therapies to treat patients with genetically defined tumors.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | (617) 252-0848 |
Industry | manufacturing |
CEO | Mark A. Velleca |
Website | www.blackdiamondtherapeutics.com |